L3VLUP
ProSign in

EWTX · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

EWTXLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • EWTX
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterEWTXLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 2020none listed holders, n.a.29 holders, $17.3bn
Q1 20213 holders, $186m24 holders, $23.0bn
Q2 20212 holders, $66m24 holders, $27.8bn
Q3 20212 holders, $51m31 holders, $29.9bn
Q4 20212 holders, $48m31 holders, $34.7bn
Q1 20222 holders, $30m24 holders, $35.3bn
Q2 20222 holders, $28m33 holders, $42.7bn
Q3 20222 holders, $49m31 holders, $43.4bn
Q4 20222 holders, $43m31 holders, $46.6bn
Q1 20232 holders, $35m33 holders, $44.3bn
Q2 20232 holders, $49m37 holders, $59.6bn
Q3 20232 holders, $37m44 holders, $67.6bn
Q4 20234 holders, $85m45 holders, $73.6bn
Q1 20244 holders, $102m41 holders, $95.3bn
Q2 20245 holders, $86m43 holders, $110bn
Q3 20246 holders, $217m45 holders, $107bn
Q4 20245 holders, $217m46 holders, $93.9bn
Q1 20255 holders, $184m42 holders, $98.4bn
Q2 20253 holders, $105m43 holders, $93.2bn
Q3 20252 holders, $92m39 holders, $86.7bn
Q4 20252 holders, $131m41 holders, $123bn
Q1 20263 holders, $212m39 holders, $106bn
Q2 20263 holders, $281m44 holders, $132bn
EWTX

Edgewise Therapeutics Inc

Holders
5
Reported value
$184m
Buyers
3
Sellers
2

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
42
Reported value
$98.4bn
Buyers
22
Sellers
22

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2025

Among the 43 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only EWTX (1)

Viking Global Investors LP

Only LLY (38)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Egerton Capital UK LLP, Eisler Capital Management Ltd, Element Capital Management LLC, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Lone Pine Capital LLC, Man Group PLC, Marshall Wace LLP, and 13 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →